News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GE Healthcare Announces CE Marking for Its Breast Tomosynthesis Solution, SenoClaire


7/16/2013 10:27:13 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BUC, France--(BUSINESS WIRE)--GE Healthcare (NYSE: GE), hailed a new era for breast imaging today as it announced CE marking for SenoClaire*, GE’s new generation of breast tomosynthesis solution designed with a three-dimensional imaging technology. Powered by ASiR*DBT 1, SenoClaire technology uses a low-dose short X-ray sweep around the positioned breast with nine exposures acquired with a “step-and-shoot” method, removing the potential motion from images.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES